IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.5900
+0.0200 (3.51%)
At close: May 30, 2025

IDL Diagnostics AB Company Description

AroCell AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cell; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever.

The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006.

AroCell AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.

IDL Diagnostics AB (publ)
Country Sweden
Founded 2000
Industry In Vitro and In Vivo Diagnostic Substances
Employees 20
CEO Anders Hultman

Contact Details

Address:
KarlsbodavAegen 39
Stockholm, 168 67
Sweden
Phone 46 87 99 67 50
Website arocell.com

Stock Details

Ticker Symbol IDLDX
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
SIC Code 2835

Key Executives

Name Position
Anders Hultman Chief Executive Officer
Maria Sundberg Chief Operating Officer